Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosis
about
A Role for Low Density Lipoprotein Receptor-Related Protein 1 in the Cellular Uptake of Tissue Plasminogen Activator in the LungsA review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis.Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayersPredicting the F(ab)-mediated effect of monoclonal antibodies in vivo by combining cell-level kinetic and pharmacokinetic modellingPharmacokinetics of recombinant bifunctional fusion proteins.Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect RatioA guide to rational dosing of monoclonal antibodies.Pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children.An Introduction to the Regulatory and Nonclinical Aspects of the Nonclinical Development of Antibody Drug Conjugates.Impact of altered endogenous IgG on unspecific mAb clearance.Quantitative measurement of the target-mediated internalization kinetics of biopharmaceuticalsExposure-Response Analysis of Necitumumab Efficacy in Squamous Non-Small Cell Lung Cancer Patients.Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification.A Tutorial on Target-Mediated Drug Disposition (TMDD) Models.Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjects.Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models.Mathematical description of drug-target interactions: application to biologics that bind to targets with two binding sites.Impact of mathematical pharmacology on practice and theory: four case studies.Target-mediated drug disposition with drug-drug interaction, Part I: single drug case in alternative formulations.Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
P2860
Q28603536-8F087552-E79D-42E3-BCBA-16592DB80E0FQ33729213-642EAA44-9E10-49CD-BDA5-B307994D6790Q35636332-805420BE-6EDC-4995-9813-9A7B9EF54050Q35905876-AE1C0C81-0362-4E95-B321-4B70BB13E498Q37033032-F78F7495-BDA0-4A39-A014-CE4436F275E8Q37551472-A09B91E2-D895-4345-9ECF-D9E751014AE7Q37976878-F090B673-1645-49B5-A8F1-3D39306540B2Q38291356-F1719842-AB8E-4C45-B75B-46A4E8B5675EQ38537261-79C3FCDB-CA14-49EB-A258-CE5C42BBDBD0Q38821722-05F429EC-3B95-451D-9FEE-30A49A39544AQ38957698-85F813B9-3939-45C7-9019-DC131823159EQ41526288-6DB99E4E-994A-4828-879E-9301F7E2E52EQ41988329-369700A4-92D9-4E2B-A6F9-35C52A8A4D80Q42351659-C0E7DADE-06D5-48A6-8E95-C0678CB4C1E3Q44019603-A8CA12D9-83A9-4D00-AC44-84FC08BDC86BQ45347262-55EE12E2-BE98-4852-B698-A4DE79F22E03Q47684512-4C9A32E2-C732-4D07-9C0E-5D98C341111AQ47694906-DB147ADE-0AF9-44F5-A0AE-F189BFDD01A0Q48015255-4548E3EB-60ED-4DC9-8B6D-5BA3C16550F4Q50216455-DE489939-1F6F-43B1-B844-6B36FD2EE0D1
P2860
Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosis
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nonlinear pharmacokinetics of ...... receptor mediated endocytosis
@ast
Nonlinear pharmacokinetics of ...... receptor mediated endocytosis
@en
type
label
Nonlinear pharmacokinetics of ...... receptor mediated endocytosis
@ast
Nonlinear pharmacokinetics of ...... receptor mediated endocytosis
@en
prefLabel
Nonlinear pharmacokinetics of ...... receptor mediated endocytosis
@ast
Nonlinear pharmacokinetics of ...... receptor mediated endocytosis
@en
P2093
P2860
P1476
Nonlinear pharmacokinetics of ...... receptor mediated endocytosis
@en
P2093
Ben-Fillippo Krippendorff
Charlotte Kloft
Katharina Kuester
Wilhelm Huisinga
P2860
P2888
P304
P356
10.1007/S10928-009-9120-1
P577
2009-06-25T00:00:00Z
P5875
P6179
1000793164